Lataa...
Anakinra in Still’s disease: a profile of its use
The EU indication for anakinra has been extended to include Still’s disease, a serious rare inflammatory disorder of unknown aetiology that comprises adult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (SJIA). As activated interleukin-1 pathways are associated with the syst...
Tallennettuna:
| Julkaisussa: | Drugs Ther Perspect |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267530/ https://ncbi.nlm.nih.gov/pubmed/30546251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40267-018-0572-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|